Abstract
Rationale/objectives
Sleep disturbance is frequent in opioid-dependent patients. To date, no data are available about the impact of methadone maintenance treatment on sleep disturbance. Using 1-year follow-up data from the Methaville trial, we investigated the impact of methadone initiation and other correlates on sleep disturbance in opioid-dependent patients.
Methods
Sleep disturbance severity was evaluated using two items from different scales (Center for Epidemiological Studies Depression Scale for depression and Opiate Treatment Index). We assessed the effect of methadone and other correlates on sleep disturbance severity during follow-up (months 0, 6, and 12) using a mixed multinomial logistic regression model.
Results
We included 173 patients who had 1-year follow-up data on sleep disturbance, corresponding to 445 visits. At enrolment, 60.5 % reported medium to severe sleep disturbance. This proportion remained stable during methadone treatment: 54.0 % at month 6 and 55.4 % at month 12. The final multivariate model indicated that younger patients (odds ratio (OR) [95 % CI] 0.95 [0.90–1.00]), patients with pain (OR [95 % CI] 2.45 [1.13–5.32]), patients with high or very high nicotine dependence (OR [95 % CI] 5.89 [2.41–14.39]), and patients at suicidal risk (2.50 [1.13–5.52]) had a higher risk of severe sleep disturbance. Because of collinearity between suicidal risk and attention deficit hyperactivity disorder (ADHD) symptoms, ADHD was not associated with sleep disturbance in the final model. Receiving methadone treatment had no significant effect on sleep disturbance.
Conclusions
Sleep disturbance is frequent among opioid-dependent patients. It can be regarded as an important signal of more complex psychiatric comorbidities such as suicidal risk and ADHD. However, sleep disturbance should not be considered an obstacle to methadone maintenance treatment (MMT) initiation or continuation.
Similar content being viewed by others
Abbreviations
- ANRS:
-
Agency for Research on Aids and Viral Hepatitis
- AUDIT:
-
Alcohol Use Disorders Identification Test
- CATI:
-
Computer-Assisted Telephone Interview
- CES-D:
-
Center for Epidemiological Studies Depression Scale
- DSM-IV:
-
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
- IQR:
-
Interquartile Range
- MINI:
-
Mini-International Neuropsychiatric Interview
- MMT:
-
Methadone Maintenance Treatment
- PSQI:
-
Pittsburgh Sleep Quality Index
- OR:
-
Odds ratio
- OTI:
-
Opiate Treatment Index
References
Aghajanian GK (1978) Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276(5684):186–188
Asaad TA, Ghanem MH, Samee AA, El-Habiby M (2011) Sleep profile in patients with chronic opioid abuse. A polysomnographic evaluation in an Egyptian sample. Addict Disord Their Treat 10:21–28
Barry DT, Beitel M, Joshi D, Schottenfeld RS (2009) Pain and substance-related pain-reduction behaviors among opioid dependent individuals seeking methadone maintenance treatment. Am J Addict 18(2):117–121
Beck AT, Weishaar ME (1990) Suicide risk assessment and prediction. Crisis 11:22–30
Bernert RA, Kim JS, Iwata NG, Perlis ML (2015) Sleep disturbances as an evidence-based suicide risk factor. Curr Psychiatry Rep 17(3):554
Brewer DD, Catalano RF, Haggerty K, Gainey RR, Fleming CB (1998) A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction 93(1):73–92
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213
Calem M, Bisla J, Begum A, Dewey M, Bebbington PE, Brugha T, Cooper C, Jenkins R, Lindesay J, McManus S, Meltzer H, Spiers N, Weich S, Stewart R (2012) Increased prevalence of insomnia and changes in hypnotics use in England over 15 years: analysis of the 1993, 2000, and 2007 National Psychiatric Morbidity Surveys. Sleep 35(3):377–384
Carpentier PJ, van Gogh MT, Knapen LJ, Buitelaar JK, De Jong CA (2011) Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients. Eur Addict Res 17(1):10–20
Carrieri PM, Michel L, Lions C, Cohen J, Vray M et al (2014) Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS methaville). PLoS One 9(11), e112328
Chan-Chee C, Bayon V, Bloch J, Beck F, Giordanella JP, Leger D (2011) Epidemiology of insomnia in France. Rev Epidemiol Sante Publique 59(6):409–422
Charpentier A, Bisac S, Poirot I, Vignau J, Cottencin O (2010) Sleep quality and apnea in stable methadone maintenance treatment. Subst Use Misuse 45(9):1431–1434
Clarke JG, Stein MD, McGarry KA, Gogineni A (2001) Interest in smoking cessation among injection drug users. Am J Addict 10(2):159–166
Cohrs S, Rodenbeck A, Riemann D, Szagun B, Jaehne A, Brinkmeyer J, Gründer G, Wienker T, Diaz-Lacava A, Mobascher A, Dahmen N, Thuerauf N, Kornhuber J, Kiefer F, Gallinat J, Wagner M, Kunz D, Grittner U, Winterer G (2014) Impaired sleep quality and sleep duration in smokers-results from the German Multicenter Study on Nicotine Dependence. Addict Biol 19(3):486–496
Daigre C, Roncero C, Rodríguez-Cintas L, Ortega L, Lligoña A, Fuentes S, Pérez-Pazos J, Martínez-Luna N, Casas M (2015) Adult ADHD screening in alcohol-dependent patients using the Wender-Utah Rating Scale and the adult ADHD Self-Report Scale. J Atten Disord 19(4):328–334
Dimsdale JE, Norman D, DeJardin D, Wallace MS (2007) The effect of opioids on sleep architecture. J Clin Sleep Med 3(1):33–36
Edwards RR, Almeida DM, Klick B, Haythornthwaite JA, Smith MT (2008) Duration of sleep contributes to next-day pain report in the general population. Pain 137(1):202–207. doi:10.1016/j.pain.2008.01.025
Eyler EC (2013) Chronic and acute pain and pain management for patients in methadone maintenance treatment. Am J Addict 22(1):75–83
Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lépine JP, Ormel J, Posada-Villa J, Zaslavsky AM, ** R (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409
Frosch DL, Shoptaw S, Jarvik ME, Rawson RA, Ling W (1998) Interest in smoking cessation among methadone maintained outpatients. J Addict Dis 17(2):9–19
Fuhrer R, Rouillon F (1989) La version française de l’échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l’échelle d’autoévaluation Psychiatr Psychobiol 4:163–166
Gache P, Michaud P, Landry U, Accietto C, Arfaoui S, Wenger O, Daeppen JB (2005) The Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version. Alcohol Clin Exp Res 29(11):2001–2007
Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS (2014) Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol 32(5):449–457
Gillin JC (1994) Sleep and psychoactive drugs of abuse and dependence. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. WB Saunders, London
Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD (1987) Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 13(3):293–308
Heatherton T, Kozlowski L, Rc F, Ko F (1991) The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict 86(9):1119–1127
Hosseinzadeh A, Hosseinalipour F (2014) Effectiveness of mindfulness-based stress reduction intervention for health-related quality of life in drug-dependent males. Iran Red Crescent Med J 16(9):e12608
Hsu WY, Chiu NY, Liu JT, Wang CH, Chang TG, Liao YC, Kuo PI (2012) Sleep quality in heroin addicts under methadone maintenance treatment. Acta Neuropsychiatr 24(6):356–360
Jamison RN, Kauffman J, Katz NP (2000) Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 19:53–62
Karow A, Verthein U, Pukrop R, Reimer J, Haasen C, Krausz M, Schäfer I (2011) Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence. Subst Use Misuse 46(6):705–715
Kay D, Pickworth W, Neidert G (1980) Morphine-like insomnia from heroin in non-dependent human addicts. Br J Clin Pharmacol 11:159–169
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4):716–723
Kim JH, Park EC, Yoo KB, Park S (2015) The Association Between Short or Long Sleep Times and Quality of Life (QOL): results of the Korea National Health and Nutrition Examination Survey (KNHANES IV-V). J Clin Sleep Med 11(6):625–634
King VL, Brooner RK, Kidorf MS, Stoller KB, Mirsky AF (1999) Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis 187(8):487–495
Kolpe M, Carlson GA (2007) Influence of attention-deficit/hyperactivity disorder symptoms on methadone treatment outcome. Am J Addict 16(1):46–48
Kupfer DJ, Reynolds CF (1997) Management of sleep disturbance. N Engl J Med 336:341–346
Lengacher CA, Reich RR, Paterson CL, Jim HS, Ramesar S, Alinat CB, Budhrani PH, Farias JR, Shelton MM, Moscoso MS, Park JY, Kip KE (2015) Psychooncology 24(4):424–432
Lewis SA, Oswald I, Evans JI, Akindele MO, Tompsett SL (1970) Heroin and human sleep. Electroencephalogr Clin Neurophysiol 28(4):374–381
Liu Y, Njai RS, Greenlund KJ, Chapman DP, Croft JB (2014) Relationships between housing and food insecurity, frequent mental distress, and insufficient sleep among adults in 12 US States, 2009. Prev Chronic Dis 11:E37
Mancino M, Curran G, Han X, Allee E, Humphreys K, Booth BM, Pud D, Zlotnick C, Lawental E (2010) Predictors of attrition from a national sample of methadone maintenance patients. Am J Drug Alcohol Abuse 36(3):155–160
Mehtry V, Nizamie SH, Parvez N, Pradhan N (2014) Sleep profile in opioid dependence: a polysomnographic case-control study. J Clin Neurophysiol 31(6):517–522
Moore P, Dimsdale JE (2002) Opioids, sleep, and cancer-related fatigue. Med Hypotheses 58(1):77–82
Morasco BJ, O’Hearn D, Turk DC, Dobscha SK (2014) Associations between prescription opioid use and sleep impairment among veterans with chronic pain. Pain Med 15(11):1902–1910
National Mental Health Information Center (2005) Suicide warning signs. Substance Abuse and Mental Health Services Administration (SAMHSA)
Ncoli-Israel S, Roth T (1999) Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I Sleep 22(suppl 2):S347–S353
Ong JC, Manber R, Segal Z, **a Y, Shapiro S, Wyatt JK (2014) A randomized controlled trial of mindfulness meditation for chronic insomnia. Sleep 37(9):1553–1563
Orr W, Stahl M (1978) Sleep patterns in human methadone addiction. Br J Addict 73:311–315
Oyefeso A, Sedgewick P, Ghodse H (1997) Subjective sleep—wake parameters in treatment-seeking opiate addicts. Drug Alcohol Depend 48:9–16
Peles E, Schreiber S, Gordon J, Adelson M (2005) Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain 113(3):340–346
Peles E, Schreiber S, Adelson M (2006) Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend 82(2):103–110
Peles E, Schreiber S, Adelson M (2009) Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose. Eur Neuropsychopharmacol 19(8):581–588, doi: 10.1016
Peles E, Schreiber S, Sutzman A, Adelson M (2012) Attention deficit hyperactivity disorder and obsessive-compulsive disorder among former heroin addicts currently in methadone maintenance treatment. Psychopathology 45(5):327–333
Pigeon WR, Pinquart M, Conner K (2012) Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry 73(9):e1160–e1167
Potter JS, Prather K, Weiss RD (2008) Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict 17:121–125
Pud D, Zlotnick C, Lawental E (2012) Pain depression and sleep disorders among methadone maintenance treatment patients. Addict Behav 37(11):1205–1210
Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK (2003) Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 289(18):2370–2378
Roux P, Michel L, Cohen J, Mora M, Morel A, Aubertin JF, Desenclos JC, Spire B, Carrieri PM, ANRS Methaville Study Group (2012) Methadone induction in primary care (ANRS Methaville): a phase III randomized intervention trial. BMC Public Health 12:488
Sharkey KM, Kurth ME, Anderson BJ, Corso RP, Millman RP, Stein MD (2010) Obstructive sleep apnea is more common than central sleep apnea in methadone maintenance patients with subjective sleep complaints. Drug Alcohol Depend 108(1-2):77–83
Shaw IR, Lavigne G, Mayer P (2005) Acute intravenous administration of morphine perturbs sleep architecture in healthy pain-free young adults: a preliminary study. Sleep 28:677–682
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33, quiz 34-57
Simon V, Czobor P, Bálint S, Mészáros A, Bitter I (2009) Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 194(3):204–211
Smith MT, Haythornthwaite JA (2004) How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev 8(2):119–132
Stark MJ (1993) Drug use and cigarette smoking in applicants for drug abuse treatment. J Subst Abus 5:175–181
Stein MD, Herman DS, Bishop S, Lassor JA, Weinstock M, Anthony J, Anderson BJ (2004) Sleep disturbances among methadone maintained patients. J Subst Abuse Treat 26(3):175–180
Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D (2015) Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med 163(3):191–204. doi:10.7326/M14-2841
Van de Glind G, Van den Brink W, Koeter MW, Carpentier PJ, Van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu ET, Franck J, Konstenius M, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Barta C, Schoevers RA, Levin FR, IASP Research Group (2013) Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend 132(3):587–596
Wang D, Teichtahl H (2007) Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev 11(1):35–46
Webster LR, Choi Y, Desai H, Webster L, Grant BJ (2008) Sleep-disordered breathing and chronic opioid therapy. Pain Med 9(4):425–432
Wilson L, Dorosz L (1984) Possible role of the opioid peptides in sleep. Med Hypotheses 14(3):269–280
**ao L, Tang YL, Smith AK, **ang YT, Sheng LX, Chi Y, Du WJ, Guo S, Jiang ZN, Zhang GF, Luo XN (2010) Nocturnal sleep architecture disturbances in early methadone treatment patients. Psychiatry Res 179(1):91–95
Youngstedt SD, Kripke DF (2004) Long sleep and mortality: rationale for sleep restriction. Sleep Med Rev 8(3):159–174
Zhang JX, Liu XH, **e XH, Zhao D, Shan MS, Zhang XL, Kong XM, Cui H (2015) Mindfulness-based stress reduction for chronic insomnia in adults older than 75 years: a randomized, controlled, single-blind clinical trial. Explore (NY) 11(3):180–185
Acknowledgments
This study received external funding from the French National Agency for Research on Aids and Viral Hepatitis (ANRS) and the French Ministry of Health. We thank all members of the ANRS Methaville Study Group. We especially thank all physicians involved in the trial and all patients who took part in this study. Finally, we thank Jude Sweeney for the English revision and editing of our manuscript.
The ANRS Methaville Study Group
Scientific Committee: P.M. Carrieri (principal investigator), A. Morel (principal investigator), L. Michel, M. Mora, P. Roux, JF. Aubertin, S. Robinet, JC. Desenclos, J. Cohen, A. Herszkowicz, C. Paul, I. Porteret, T. Sainte Marie.
Safety committee: J. Bachellier, P. Beauverie, JP Couteron, C. Marty-Double, M. Vray.
International committee of experts: R. Baker, H. Catania, M. Gossop, R. Haemmig, M. Torrens, A. Wodak.
Physicians: Dr. Achard, Dr. Aizpurua, Dr. Aubertin, Dr. Azalbert, Dr. Balteaubijeau, Dr. Bartolo, Dr. Berger, Dr. Bibette, Dr. Biderman, Dr. Blochlaine, Dr. Cadart, Dr. Casenave, Dr. Castera, Dr. Causse, Dr. Corlieu, Dr. Delile, Dr. Demasse, Dr. Depieds, Dr. Dewost, Dr. Drosson, Dr. Duffez, Dr. Faust, Dr. Gassmann, Dr. Guena, Dr. Guillet, Dr. Gutenkust, Dr. Herouin, Dr. Herran, Dr. Heitz, Dr. Kerloc’h, Dr. Khouri, Dr. Lang, Dr. Lasalarie, Dr. Lavignasse, Dr. Magnin, Dr. Maire, Dr. Margelis, Dr. Marre, Dr. Mauraycaplanne, Dr. Michel, Dr. Morel, Dr. Nemayech, Dr. Noss, Dr. Pages, Dr. Paillou, Dr. Partouche, Dr. Petit, Dr. Pouclet, Dr. Raulin, Dr. Regard, Dr. Reiller, Dr. Roch, Dr. Rouille, Dr. Sananes, Dr. Sangare, Dr. Truffy, Dr. Vergez, Dr. Vincent, Dr. Wajsbrot.
Centre of Methodology and Management, INSERM U912
Protocol, guidelines, training: MP. Carrieri, L. Michel, M. Mora, P. Roux.
Phone interviews, training, logistics: G. Maradan, J. Biemar, S. Huguet.
Data collection, management, and statistical analyses: P. Kurkdji, C. Taieb, J. Cohen.
Administration: C. Giovannini, MP. Kissikian.
AIDS agency (ANRS): JC. Desenclos, N. Job-Spira, V. Dore, C. Paul, I. Porteret.
French agency for the safety of health products (AFSSPAS): N. Richard.
French Ministry of Health: A. Herszkowicz, N. Prisse.
ASUD association: F. Olivet; AIDES association
Centre of evaluation and information on drug dependence (CEIP): J. Arditti
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have nothing to disclose regarding funding or conflict of interest with respect to this manuscript.
Rights and permissions
About this article
Cite this article
Nordmann, S., Lions, C., Vilotitch, A. et al. A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study). Psychopharmacology 233, 1203–1213 (2016). https://doi.org/10.1007/s00213-016-4202-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-016-4202-4